| For: | Udupa KB. Functional significance of erythropoietin receptor on tumor cells. World J Gastroenterol 2006; 12(46): 7460-7462 [PMID: 17167833 DOI: 10.3748/wjg.v12.i46.7460] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v12/i46/7460.htm |
| Number | Citing Articles |
| 1 |
Xiangyue Zhang, Edgar G. Engleman. Erythropoietin impacts immune adaptation through myeloid-cell programming. Trends in Immunology 2026; doi: 10.1016/j.it.2026.08.014
|
| 2 |
Milljae Shin, Doopyo Hong, Zhengyun Zhang, You Min Kim, Wookjong Lee, Jae-Won Joh, Sung-Joo Kim. Expression and functional significance of the erythropoietin receptor in hepatocellular carcinoma. HPB 2013; 15(12) doi: 10.1111/hpb.12076
|
| 3 |
Damian Szczesny, Katarzyna Mołoniewicz, Michał J. Markuszewski, Paweł Wiczling. Proof-of-concept study on improved efficacy of rHuEPO administered as a long-term infusion in rats. Pharmacological Reports 2020; 72(5) doi: 10.1007/s43440-020-00150-x
|
| 4 |
Tiziana Annese, Roberto Tamma, Simona Ruggieri, Domenico Ribatti. Erythropoietin in tumor angiogenesis. Experimental Cell Research 2019; 374(2) doi: 10.1016/j.yexcr.2018.12.013
|
| 5 |
Patnarin Mahattanasakul, Komkrit Ruangritchankul, Areeya Diloktaweewattana, Supranee Buranapraditkun, Nakarin Kitkumthorn. Plasma cytokine profiles in oral and oropharyngeal squamous cell carcinoma. BMC Oral Health 2025; 25(1) doi: 10.1186/s12903-025-06942-y
|
| 6 |
Michael Hines, Lars Nielsen, Justin Cooper‐White. The hematopoietic stem cell niche: what are we trying to replicate?. Journal of Chemical Technology & Biotechnology 2008; 83(4) doi: 10.1002/jctb.1856
|
| 7 |
Irina Stoian, Bogdan Manolescu, Valeriu Atanasiu, Olivera Lupescu. New alternatives for erythropoietin therapy in chronic renal failure. Open Medicine 2007; 2(4) doi: 10.2478/s11536-007-0038-y
|
| 8 |
Chhanda Bose, Kodetthoor B. Udupa. Erythropoietin enhancement of rat pancreatic tumor cell proliferation requires the activation of ERK and JNK signals. American Journal of Physiology-Cell Physiology 2008; 295(2) doi: 10.1152/ajpcell.00423.2007
|
| 9 |
E. Digkas, D. Kareli, S. Chrisafi, T. Passadaki, E. Mantadakis, A. Hatzimichail, V. Vargemezis, Th. Lialiaris. Attenuation of cytogenetic effects by erythropoietin in human lymphocytes in vitro and P388 ascites tumor cells in vivo treated with irinotecan (CPT-11). Food and Chemical Toxicology 2010; 48(1) doi: 10.1016/j.fct.2009.10.007
|
| 10 |
Hui-Ying Liu. Recurrence risk of erythropoiesis-stimulating agents on early-stage urothelial carcinoma in patients with end stage renal disease. American Journal of Cancer Research 2024; 14(11) doi: 10.62347/UJAT9290
|